High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Genes
Volume 13, Issue 5, Pages 876
Publisher
MDPI AG
Online
2022-05-14
DOI
10.3390/genes13050876
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy
- (2022) Shanshan Sun et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
- (2022) Yu-Chuan Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
- (2022) Chen Xue et al. Frontiers in Immunology
- EZH2 Mediates Proliferation, Migration, and Invasion Promoted by Estradiol in Human Glioblastoma Cells
- (2022) Aylin Del Moral-Morales et al. Frontiers in Endocrinology
- Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review
- (2022) Alberto Servetto et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The evolutionary legacy of immune checkpoint inhibitors
- (2022) Itishree Kaushik et al. SEMINARS IN CANCER BIOLOGY
- Single-molecule imaging of microRNA-mediated gene silencing in cells
- (2022) Hotaka Kobayashi et al. Nature Communications
- The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma
- (2022) Yuanyuan Guo et al. Frontiers in Immunology
- A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma
- (2022) Lianghua Luo et al. Frontiers in Genetics
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Advances in immunotherapy for hepatocellular carcinoma
- (2021) Bruno Sangro et al. Nature Reviews Gastroenterology & Hepatology
- Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
- (2021) Jiacheng Huang et al. Frontiers in Oncology
- PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis
- (2021) Zhongwei Li et al. Cell Death & Disease
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
- (2021) et al. JAMA Oncology
- Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR‐218‐5p/DEAD‐box helicase 5 (DDX5) axis
- (2020) Huibo Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis
- (2020) Ningfu Peng et al. Cancer Cell International
- SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
- (2020) Huairui Yuan et al. CANCER CELL
- Inhibition of EZH2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway
- (2020) Boyan Huang et al. Gastric Cancer
- EZH2: a novel target for cancer treatment
- (2020) Ran Duan et al. Journal of Hematology & Oncology
- EZH2 regulates pancreatic cancer subtype identity and tumor progression via transcriptional repression of GATA6
- (2020) Shilpa Patil et al. CANCER RESEARCH
- Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis
- (2020) Zhongwei Li et al. CELL DEATH AND DIFFERENTIATION
- Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p
- (2020) Feiyu Chen et al. Clinical and Translational Medicine
- Immunotherapy for advanced hepatocellular carcinoma, where are we?
- (2020) Li Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Immunometabolic Interplay in the Tumor Microenvironment
- (2020) Irem Kaymak et al. CANCER CELL
- LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution
- (2020) Peng Wang et al. NUCLEIC ACIDS RESEARCH
- Tumor microenvironment as a therapeutic target in cancer
- (2020) Yi Xiao et al. PHARMACOLOGY & THERAPEUTICS
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
- (2019) Qiang Gao et al. CELL
- ncRNA-Encoded Peptides or Proteins and Cancer
- (2019) Jizhong Wang et al. MOLECULAR THERAPY
- EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
- (2018) Shaofei Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
- (2018) Lu Gan et al. Journal of Hematology & Oncology
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling
- (2018) Ling-jie Sang et al. MOLECULAR CELL
- Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
- (2017) Sara Torrecilla et al. JOURNAL OF HEPATOLOGY
- Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma
- (2016) Lei Chang et al. CANCER LETTERS
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
- (2016) Run Zhai et al. OncoTargets and Therapy
- EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma
- (2015) Haiou Liu et al. Nature Communications
- Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis
- (2014) Yanrui Sheng et al. Biochemistry and Cell Biology
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
- (2011) Fang Zheng et al. GUT
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started